Oral Ulcer Clinical Trial
Official title:
Oral Ulcer Prevalence of and Quality of Life: a Hospital-based Cross-sectional Study
Verified date | May 2017 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Oral Ulcers have serious effect on patients' lives. Due to absence of any information about its prevalence, risk factors and effect on patients' lives, this study has been held. The investigators recruited patients from the outpatient dental clinic of the faculty of oral and dental medicine, Cairo University, screened them clinically for oral ulcers. All patients filled questionnaires about the risk factors of oral ulcers. Furthermore, oral ulcer patients filled questionnaires about their Quality of life, previous treatments used, previous physicians visited and their Quality of life after using previous treatments.
Status | Completed |
Enrollment | 605 |
Est. completion date | October 25, 2015 |
Est. primary completion date | October 25, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years and older |
Eligibility |
Inclusion Criteria: - Subjects whose age was above 15 years old. Exclusion Criteria: - Subjects having problem in opening their mouth (due to non-oral ulcer cause) or undergoing intermaxillary fixation where oral examination was not possible. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | prevalence of Oral Ulcers | number of patients having oral ulcers | 3 months | |
Secondary | Oral health related-quality of life (OHR-QoL). | Quality of life of patients having oral ulcers | 3 months | |
Secondary | The effect of previous treatment | measured by: OHIP-14 at the end of treatment and the time interval of ulcer-free period after stoppage of treatment. | 3 months | |
Secondary | Types of non-conventional treatments used | reported together with its side effects as nominal outcomes. | 3 months | |
Secondary | Number of dentists or physicians visited before | Also the specialties of these physicians reported | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03239834 -
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
|
||
Not yet recruiting |
NCT04989049 -
Therapeutic Effect of Folic Acid in Healing of Oral Ulcers
|
Early Phase 1 | |
Completed |
NCT06379438 -
Treatment of Aphtous Ulcers With Photodynamic Therapy
|
N/A | |
Withdrawn |
NCT02769494 -
The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer
|
Phase 3 | |
Completed |
NCT05413096 -
Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis
|
Early Phase 1 | |
Completed |
NCT03633292 -
Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers
|
Phase 4 | |
Completed |
NCT00333749 -
The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
|
Phase 1 | |
Recruiting |
NCT04710888 -
Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis
|
Phase 2 | |
Completed |
NCT05147376 -
Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances
|
Early Phase 1 | |
Completed |
NCT04383236 -
Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis
|
N/A | |
Enrolling by invitation |
NCT05288478 -
Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa.
|
Phase 2 | |
Recruiting |
NCT05449548 -
Lenalidomide in the Treatment of Mucosal Behçet's Syndrome
|
N/A | |
Completed |
NCT05032248 -
Uses of Tacrolimus in Behcet Disease
|
N/A |